Konjević G, Spuzić I
Srp Arh Celok Lek. 1994;122 Suppl 1:78-80.
In previous reports it was shown that sera of patients with breast cancer in the early clinical stage enhance the activity of NK cells of healthy persons and patients, and that this effect disappears with the advance of the disease. In this studi the effect of sera of 33 breast cancer patients with metastases on NK cell activity of healthy controls was investigated. All of the sera had an inhibitory effect (5 to 84% compared to control sera), the average inhibition obtained by all of the investigated sera was 44% and in one third it was more than 60%. In 21 of 33 patients an increase in the level of immune complexes was found. Investigation of immunoglobulins showed an increase in 12 parients mostly of IgG, which was well correlated with the findings of immune complexes. These investigations clearly show that sera of patients with metastases have an inhibitory effect on NK cell activity of healthy controls, and this most likely contributes to the lower activity of NK cells of patients in advanced stages of this disease, as well as that these sera most often have increased immune complexes, although this was not always proportional to the observed inhibitory effect.
在先前的报告中显示,处于临床早期的乳腺癌患者血清可增强健康人和患者的自然杀伤细胞(NK细胞)活性,且随着病情进展这种效应会消失。在本研究中,对33例有转移的乳腺癌患者血清对健康对照者NK细胞活性的影响进行了调查。所有血清均有抑制作用(与对照血清相比为5%至84%),所有被调查血清的平均抑制率为44%,三分之一的血清抑制率超过60%。在33例患者中有21例发现免疫复合物水平升高。免疫球蛋白检测显示12例患者升高,主要是IgG升高,这与免疫复合物的检测结果密切相关。这些研究清楚地表明,有转移的患者血清对健康对照者的NK细胞活性有抑制作用,这很可能是导致该疾病晚期患者NK细胞活性较低的原因,并且这些血清中免疫复合物大多增多,尽管这并不总是与观察到的抑制作用成正比。